首页 | 本学科首页   官方微博 | 高级检索  
     

自体骨髓移植结合定期维持化疗治疗恶性血液病14例临床分析
引用本文:夏学鸣 林宝爵. 自体骨髓移植结合定期维持化疗治疗恶性血液病14例临床分析[J]. 中国肿瘤临床, 1998, 25(11): 800-802
作者姓名:夏学鸣 林宝爵
作者单位:苏州医学院附属一院血液科,江苏省血液研究所
摘    要:自体骨髓移植(ABMT)治疗恶性血液病国内正在广泛开展,其缺点是易复发。采用ABMT结合定期维持化疗的方法治疗恶性血液病。结果14例患者中,9例移植后已持续完全缓解35~95个月,中位数为78个月。证明ABMT结合定期维持化疗,可以减少复发率和延长无病生存期

关 键 词:恶性血液病  自体骨髓移植  维持化疗  疗效

Periodic Maintenance Chemotherapy following Autologous Bone Marrow Transplantation A Clinical Analysis of 14 Cases of Hematologic Malignancies
Xia Xueming Lin Baojue Wu Depei et al Jiangsu Institute of Hematology,First Hospital of Suzhou Medical College,Suzhou. Periodic Maintenance Chemotherapy following Autologous Bone Marrow Transplantation A Clinical Analysis of 14 Cases of Hematologic Malignancies[J]. Chinese Journal of Clinical Oncology, 1998, 25(11): 800-802
Authors:Xia Xueming Lin Baojue Wu Depei et al Jiangsu Institute of Hematology  First Hospital of Suzhou Medical College  Suzhou
Abstract:Autologous Bone Marrow Transplantation (ABMT) has been extensively used in the treatment of hematologic malignancies, but with a high relapse rate. Periodic maintenance chemotherapy following ABMT was used in 14 cases of hematologic malignancies in our institute. The results showed that 9 patients had been in continuous complete remission for 35 to 95 months (median remission period 78 months).It suggests that ABMT combining maintenance chemotherapy could reduce relapse rate and that it could prolong the disease free survival.
Keywords:Hematologic malignancies Autologous bone marrow transplantation Maintenance chemotherapy  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号